Jack West, MD, FASCO

jackwestmd.bsky.social

02 December 2024 23:59

Pushing Back on Pie Charts Though pie charts are a staple of oncology & especially favored for molecular oncology, they have several problems that make them a poor choice for conveying data clearly. I say this knowing that one like the one here was a cornerstone of my presentations for years. (1/7)

Stephen Liu

stephenvliu.bsky.social

26 November 2024 18:26

Press release: phase III SKYSCRAPER-01 study negative for OS at final analysis. Adding anti-TIGIT tiragolumab to first line atezolizumab in advanced PDL1 high NSCLC did not improve PFS or OS. Now to dissect what happened between phase II and III. www.gene.com/media/press-...

najarvg.bsky.social

19 November 2024 20:09

Indeed. Now, atleast amongst NCI certified cancer centers, barring any with significant logistical issues, word on the street is that accruals have generally recovered back to pre-covid levels. So hopefully such murky tactics are not needed..

najarvg.bsky.social

18 November 2024 22:38

Definitely ethically very murky. Don't know that the law states it one way or the other but medical ethics/compliance departments may take a dim view if this done at a hospital or medical center (US viewpoint fwiw)

Kapalı içerik